Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adverse Drug Reaction Frequency Investigation of TSUMURA Hochuekkito Extract Granules
jRCT1080225055Completed
- Sponsor
- Tsumura & Co.
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of buzhong yiqi in asthenia, Tuberculosis (TB), anorexia nervosa (AN) and 10 more, sponsored by Tsumura & Co. Primary endpoint: Frequency of adverse drug reactions. Started Feb 2020; status: completed.
02
Drugs
buzhong yiqi
03
Conditions
astheniaTuberculosis (TB)anorexia nervosa (AN)gastroptosisupper respiratory infection (URI)
Beyond the preview
Go deeper on jRCT1080225055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080225055.